Patents Represented by Attorney, Agent or Law Firm Shanks & Herbert
  • Patent number: 6541221
    Abstract: Expression of an endogenous gene is activated or increased following integration into a cell, by non-homologous or illegitimate recombination, of (1) an enhancer sequence that activates expression of the gene and (2) a sequence that encodes an amplifiable marker. The invention also provides methods for the identification, activation, isolation, and/or expression of genes undiscoverable by current methods since no target sequence is necessary for integration. The invention also provides cells containing the enhancer and amplifiable marker sequence and expressing increased amounts of a desired gene. The invention also provides methods for the isolation of nucleic acid molecules (particularly cDNA molecules) encoding a variety of proteins, including transmembrane proteins, and for the isolation of cells expressing such proteins.
    Type: Grant
    Filed: January 11, 2000
    Date of Patent: April 1, 2003
    Assignee: Athersys, Inc.
    Inventors: John J. Harrington, Bruce Sherf, Stephen Rundlett
  • Patent number: 6536160
    Abstract: A houseplant maintenance device having a base, a water reservoir, one or more wick elements, and wick holder is disclosed. The wick element draws liquid nutrients from the reservoir and makes it available to the plant growing medium, the wick element is capable of being positioned, relative to the water level in the reservoir, to adjust the liquid nutrient delivery rate, both pre-planting and post-planting. Additionally, the wick element can be chemically bonded to provide means to deliver nutrient cations to a potted plant from solid nutrients that are otherwise not readily soluble in water.
    Type: Grant
    Filed: November 16, 2000
    Date of Patent: March 25, 2003
    Assignee: Lynn Morlier
    Inventors: Lynn W. Morlier, Christopher G. Greve, Ronald M. O'Connor
  • Patent number: 6533958
    Abstract: A method of controlling microbial fouling is provided. The method controls microbial fouling using hypobromous acid, HOBr, formed by the reaction between an aqueous solution of alkali or alkaline earth metal hypochlorite and a bromide ion source. The method is characterized in that the alkali or alkaline earth metal hypochlorite or/and the bromide ion source is/are stabilized by the addition of a stabilizer before the hypobromous acid is formed by the reaction there between.
    Type: Grant
    Filed: September 13, 2001
    Date of Patent: March 18, 2003
    Assignee: Acculab Co., Ltd.
    Inventors: Sang Hea Shim, Chung Soo Kim
  • Patent number: 6528133
    Abstract: The present invention provides a polyester heat-shrinkable tube for coating electrolytic condenser molded from a resin composition comprising a) 80 to 99 wt % of a copolymerized polyester resin with an intrinsic viscosity of 0.65 to 1.0 dl/g, which comprises 1 to 15 mol % of polyethylene naphthalate and 85 to 90 mol % of polyethylene terephthalate, and b) 1 to 20 wt % of polybutylene terephthalate resin. The polyester heat-shrinkable tube of the present invention has superior heat resistance, strength and coating-adhesion property, so that no cracks may occur in dry-heat treatment after the coating and contraction step, and also that the tube can be tightly adhered to the condenser.
    Type: Grant
    Filed: August 17, 2000
    Date of Patent: March 4, 2003
    Assignee: Kolon Industries, Inc.
    Inventors: Young-Seok Kim, Jun-Myoung Song, Kuk-Ung Kim
  • Patent number: 6528445
    Abstract: Disclosed is a dielectric ceramic composition suitable for use in planar or multilayer type electronic parts containing inner conductors, for the fabrication of which simultaneously sintering base materials and conductors is required.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: March 4, 2003
    Inventors: Kug Sun Hong, Jung-Kun Lee, Dong-Wan Kim, Hyun-Woo Jung, Jeong-Ryeol Kim, Sang-Gu Kang, Do-Kyun Kwon
  • Patent number: 6524824
    Abstract: Expression of an endogenous gene is activated or increased following integration into the cell, by non-homologous or illegitimate recombination, of a regulatory sequence that activates expression of the gene. The invention also provides methods for the identification, activation, isolation, and/or expression of genes undiscoverable by current methods since no target sequence is necessary for integration. The invention also provides methods for the isolation of nucleic acid molecules (particularly cDNA molecules) encoding a variety of proteins, including transmembrane proteins, and for the isolation of cells expressing such transmembrane proteins which may be heterologous transmembrane proteins. Thus, by the present invention, endogenous genes, including those associated with human disease and development, may be activated and isolated without prior knowledge of the sequence, structure, function, or expression profile of the genes.
    Type: Grant
    Filed: January 12, 2000
    Date of Patent: February 25, 2003
    Assignee: Athersys, Inc.
    Inventors: John J. Harrington, Bruce Sherf, Stephen Rundlett
  • Patent number: 6523709
    Abstract: The present invention relates to a reversible child resistant cap and a closure system having two positions, the first being a child resistant position and the other being a non-child resistant position. The cap is characterized in that it has a closure plane, a circumferential outer skirt for engaging a container, and a circumferential resilient depending inner member.
    Type: Grant
    Filed: September 9, 2002
    Date of Patent: February 25, 2003
    Assignee: Tri State Distribution, Inc.
    Inventors: David A. Miceli, Joseph A. Miceli
  • Patent number: 6524818
    Abstract: The present invention is directed generally to activating gene expression or causing over-expression of a gene by recombination methods in situ. The invention also is directed generally to methods for expressing an endogenous gene in a cell at levels higher than those normally found in the cell. In one embodiment of the invention, expression of an endogenous gene is activated or increased following integration into the cell, by non-homologous or illegitimate recombination, of a regulatory sequence that activates expression of the gene. In another embodiment, the expression of the endogenous gene may be further increased by co-integration of one or more amplifiable markers, and selecting for increased copies of the one or more amplifiable markers located on the integrated vector. In another embodiment, the invention is directed to activation of endogenous genes by non-targeted integration of specialized activation vectors, which are provided by the invention, into the genome of a host cell.
    Type: Grant
    Filed: January 18, 2000
    Date of Patent: February 25, 2003
    Assignee: Athersys, Inc.
    Inventors: John J. Harrington, Bruce Sherf, Stephen Rundlett
  • Patent number: 6521640
    Abstract: The present invention provides a new of sulfasalazine as a potent agent for the treatment of neuronal death.
    Type: Grant
    Filed: April 21, 2000
    Date of Patent: February 18, 2003
    Assignee: Neurotech Co., Ltd.
    Inventors: Byoung Joo Gwag, Young Ae Lee, Bo Rum Ryu
  • Patent number: 6514589
    Abstract: This invention relates to a solar control film that blocks the sunlight, when applied to various windows of automobiles, buildings or exhibition places and that prevent any second accident caused by broken glasses at an accident. From the solar control film, a surface protective layer, a plastic film substrate, a hologram-engraved layer, a metal deposition layer, a pressure sensitive adhesive layer and a release film are laminated in due order. The solar control film of this. Hence the above-described solar film has a basic function such as an excellent blocking rate of visible and infrared rays, while demonstrating an additional antifog action and an elegant look due to the hologram effect.
    Type: Grant
    Filed: August 14, 2000
    Date of Patent: February 4, 2003
    Assignee: Kolon Industries, Inc.
    Inventors: Won Suk Chang, Jong Min Park, Chang Sup Ji
  • Patent number: 6506818
    Abstract: The polyester composition for films includes, based on 100 parts by weight of a polyester resin, 0.01 to 5 parts by weight of aluminum silicate particles containing aluminum and silica as principal components and an alkali metal. To provide polyester films suitable for magnetic recording media, the polymer composition contains surface- modified aluminum silicate particles and two additional particles distinct in particle diameter. The polyester films thus obtained have excellent abrasion resistance and scratch resistance.
    Type: Grant
    Filed: November 21, 2000
    Date of Patent: January 14, 2003
    Assignee: Kolon Industries, Inc.
    Inventors: Wooseok Choi, Sangbong Park
  • Patent number: 6495541
    Abstract: Compounds of the formula below are poly(ADP-ribosyl)transferase (PARP) inhibitors, and are useful as therapuetics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and nuerodegenerative disease. As cancer therapuetics, the compounds of the invention may be used, e.g., in combination with cytotoxic agents and/or radiation.
    Type: Grant
    Filed: January 10, 2000
    Date of Patent: December 17, 2002
    Assignee: Agouron Pharmaceuticals, Inc.
    Inventors: Stephen Evan Webber, Stacie S. Canan-Koch, Jayashree Tikhe, Lars Henrik Thoresen
  • Patent number: 6496827
    Abstract: The centralized collection of geographically distributed data is accomplished using a system which takes advantage of an interactive programming language, such as Java® and existing wide area networks, such as the Internet including the world wide web (4), to collect high quality data in an information center (10). The information center being connected to remote sites (1) through the wide area network. One or more levels of validation of the data prior to storage in a database is provided for.
    Type: Grant
    Filed: January 28, 2000
    Date of Patent: December 17, 2002
    Assignee: MLK Software
    Inventors: Marc L. Kozam, Louis Y. Korman
  • Patent number: 6492402
    Abstract: The present invention relates to a compound having formula I: and pharmaceutically acceptable salts thereof. The compounds of formula I and pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants.
    Type: Grant
    Filed: December 29, 1999
    Date of Patent: December 10, 2002
    Assignee: LG Life Sciences, Ltd.
    Inventors: Koo Lee, Won Hyuk Jung, Cheol Won Park, Sang Koo Lee, Sun Hwa Lee, Hee Dong Park
  • Patent number: 6472020
    Abstract: A process for forming a multilayer coating film on automotive bodies which comprises applying a clear coating for top coating, by the wet-on-wet technique, onto a base coating containing a color pigment and/or a luster pigment as applied to a coated automotive panel and then heating the coat layers for curing, said base coating comprising, as resin constituents, a product obtained by grafting a silicate compound (A) onto a hydroxyl-containing acrylic resin or polyester resin and a melamine type curing agent.
    Type: Grant
    Filed: June 1, 2001
    Date of Patent: October 29, 2002
    Assignee: Nippon Paint Co., Ltd.
    Inventors: Manabu Yoshioka, Teruzo Toui
  • Patent number: 6469021
    Abstract: Non-peptide compounds that act as antagonists of the intestinal hormone glucagons-like peptide 1 (GLP-1) have a 9H-b-carboline central motif. The compounds exhibit advantageous physical, chemical and biological properties and inhibit GLP-1 peptide binding to the GLP-1 receptor and/or prevent activation of the receptor by bound GLP-1. The invention further relates to a method of inhibiting the binding of GLP-1 to the GLP-1 receptor and a method of inhibiting the activation of the GLP-1 receptor. Intermediate compounds useful for making non-peptide GLP-1 receptor antagonists are also described.
    Type: Grant
    Filed: October 26, 2001
    Date of Patent: October 22, 2002
    Assignee: Agouron Pharmaceuticals, Inc.
    Inventors: Larry Kenneth Truesdale, Richard A. Bychowski, Javier Gonzalez, Atsuo Kuki, Ranjan Jagath Rajapakse, Min Teng, Dan Kiel, Daljit S. Dhanoa, Yufeng Hong, Tso-sheng Chou, Anthony L. Ling, Michael David Johnson, Vlad Edward Gregor
  • Patent number: 6465038
    Abstract: A tray set composed of a first tray and a second tray, wherein the first tray having a plurality of depressed portions in which sushi toppings can be placed and which each has a shape having a depth so as to fill it with the sushi topping and a portion of a lump of rice seasoned with vinegar. The first tray is provided with a plurality of holes on the bottom so as for liquid dropped or oozed out from the toppings to be discharged therethrough. The second tray is arranged such that it can be laid under the first tray and the liquid discharged from the first tray can be received by a depressed face, and a plurality of projections are formed continually and integrally with the depressed face and the plurality of the projections are disposed so as to be engageable with the holes of the first tray and to project through the holes inside the first tray, when the second tray is laid under the first tray. The projections assist in separating the sushi from the tray.
    Type: Grant
    Filed: February 5, 2001
    Date of Patent: October 15, 2002
    Assignee: Fuji Seiko Co., Ltd.
    Inventor: Minoru Aoki
  • Patent number: 6462060
    Abstract: Compounds with heterocyclic-hydroxyimino-fluorene nuclei that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction in order to modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer as well as other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.
    Type: Grant
    Filed: August 16, 2001
    Date of Patent: October 8, 2002
    Assignee: Agouron Pharmaceuticals, Inc.
    Inventors: Wesley Kwon Mung Chong, Rohit Kumar Duvadie
  • Patent number: 6462069
    Abstract: Amino-pyrazole compounds that modulate and/or inhibit the activity of protein kinases. These compounds and pharmaceutical compositions containing them are capable of mediating and/or inhibiting the activity cyclin-dependent kinases, thereby modulating and/or inhibiting unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer as well as other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.
    Type: Grant
    Filed: April 17, 2001
    Date of Patent: October 8, 2002
    Assignee: Agouron Pharmaceuticals, Inc.
    Inventors: Siegfried Heinz Reich, Michael B. Wallace
  • Patent number: 6446823
    Abstract: The present invention relates to a reversible child resistant cap and a closure system having two positions, the first being a child resistant position and the other being a non-child resistant position. The cap is characterized in that it has a closure plane, a circumferential outer skirt for engaging a container, and a circumferential resilient depending inner member.
    Type: Grant
    Filed: February 28, 2001
    Date of Patent: September 10, 2002
    Assignee: Tri State Distribution, Inc.
    Inventors: David A. Miceli, Joseph A. Miceli